SMARCA4 and neoplasm: Previous studies showed that SMARCA4 knockdown caused replicative stress and decreased p21 expression by reducing the binding of p53 to its promoter, suggesting that functional loss of both SMARCA4 and p53 may increase tumor vulnerability to therapy [38,39].